A ferret model of electrical-induction of arterial thrombosis that is sensitive to aspirin

Journal of Pharmacological and Toxicological Methods

Volumn 35, Issue 1, 1996, Pages 3-10

  Schumacher, William A ^a   Steinbacher, Thomas E ^a   Megill, John R ^a   Durham, Stephen K ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

Arterial thrombosis; Aspirin; Blood coagulation; Ferret; Platelet aggregation; Thromboxane inhibitor

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; COLLAGEN; IFETROBAN; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE A2 RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; CAROTID ARTERY FLOW; CONTROLLED STUDY; DRUG SENSITIVITY; ELECTRON MICROSCOPY; ELECTROSTIMULATION; FERRET; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROSCOPY; NONHUMAN; RAT; SPECIES DIFFERENCE; THROMBOCYTE AGGREGATION;

EID: 0029985641     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8719(95)00099-2     Document Type: Article

References (23)

1. Ashida S, Sakuma K, Abiko Y (1980) Antithrombotic effects of ticlopidine, acetylsalicylic acid and dipyridamole in vascular shunt model in rats. Thromb Res 17:663-671.
2. Burke SE, Leffer AM, Nicolaou KC, Smith GM, Smith JB (1983) Responsiveness of platelets and coronary arteries from different species to sythetic thromboxane and prostaglandin endoperoxide analogues. Br J Pharmacol 78:287-292.
3. Bush LR, Shebuski RJ (1990) In vivo models of arterial thrombosis and thrombolysis. FASEB J 4:3087-3098.
4. Gomoll AW, Lekich RF (1990) Use of the ferret for a myocardial ischemia/salvage model. J Pharmacol Methods 23:213-223.
5. Gomoll AW, Ogletree ML (1995) Failure of aspirin to interfere with the cardioprotective effects of ifetroban. Eur J Pharmacol 271:471-479.
6. Gomoll AW, Schumacher WA, Ogletree ML (1995) Dose-related cardioprotection by ifetroban in relation to inhibition of ex vivo platelet function and thrombosis. Pharmacology 50:92-110.
7. Hladovec J (1973) Experimental arterial thrombosis in rats with continuous registration. Thromb Diath Haemorrh 29:407-410.
8. Massad L, Plotkine M, Capdeville C, Boulu RG (1987) Electrically induced arterial thrombosis model in the conscious rat. Thromb Res 48:1-10.
9. McDowell EM, Trump BF (1976) Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med 100:405-414.
10. Nakano T, Hanasaki K, Arita H (1989) Role of protein kinase C in U46619-induced platelet shape change, aggregation and secretion. Thromb Res 56:299-306.
11. 2/prostaglandin endoperoxide receptor antagonist. J Pharmacol Exp Ther 264:570-578.
12. Parris J, Fournau P, Granero M, Veins C (1983) Antithrombotic effect of very low doses of acetylsalicyclic acid in rats. Thromb Res 28:313-321.
13. Philp RB, Paul ML, Killackey JJ, Killackey BA (1983) The influence of dose, time of administration, body temperature and salicylate kinetics on the antithrombotic action of acetylsalicylic acid in male rats. Haemostasis 13:42-52.
14. Romson JL, Haack DW, Lucchesi BR (1980) Electrical induction of coronary artery thrombosis in the ambulatory canine: A model for in vivo evaluation of anti-thrombotic drugs. Thromb Res 17:841-853.
15. Salazar AE (1961) Experimental myocardial infarction, induction of coronary thrombosis in the intact closed-chest dog. Circ Res 9:1351-1356.
16. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J (1991) Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 87:571-580.
17. Schumacher WA, Heran CL (1989) Effect of thromboxane antagonism on recanalization during streptokinase-induced thrombolysis in anesthetized monkeys. J Cardiovasc Pharmacol 13:853-861.
18. Schumacher WA, Heran CL, Steinbacher TE, Megill JR, Bird JE, Giancarli MR, Durham SK (1992) Thrombin inhibition compared with other antithrombotic drugs in rats. Thromb Res 68:157-166.
19. Schumacher WA, Heran CL, Steinbacher TE, Youssef S, Ogletree ML (1993a) Superior activity of a thromboxane receptor antagonist compared to aspirin in experimental arterial and venous thrombosis. J Cardiovasc Pharmacol 22:526-533.
20. Schumacher WA, Steinbacher TE, Heran CL, Megill JR, Durham SK (1993b) Effects of antithrombotic drugs in a rat model of aspirin-insensitive arterial thrombosis. Thromb Haemost 69:509-514.
21. Van der Giessen WJ (1989) The effect of the thromboxane receptor antagonist BM 13,177 on experimentally induced coronary artery thrombosis in the pig. Eur J Pharmacol 147:241-248.
22. 2 synthase inhibition alone and in combination: Comparison of anti-aggregatory efficacy in human platelets. Br J Pharmacol 102:497-505.
23. Zweiler AJ (1967) Impairment of platelet function and thrombus growth in reserpine-treated rabbits. J Lab Clin Med 70:16-20.